Table 2.
Characteristics of KS in HIV+ Patients on First Hospital Admission with Active KS
| n (%) | |
|---|---|
| ACTG staging | |
| Tumor | |
| 0 | 29 (67) |
| 1 | 14 (33) |
| Immune | |
| 0 | 3 (7) |
| 1 | 40 (93) |
| System | |
| 0 | 11 (26) |
| 1 | 32 (74) |
| Location of KS | |
| Skin | 32 (74) |
| Lung | 18 (42) |
| GI | 15 (35) |
| Lymphatic | 12 (28) |
| Oral | 9 (21) |
| Liver, spleen, or kidney | 3 (7) |
| Bone | 2 (5) |
| Number of organ systems involved | |
| 1 | 14 (33) |
| 2 | 14 (33) |
| 3+ | 15 (35) |
ACTG, AIDS clinical trial group.